VERONICA BOLEY: Open Payments
NPI 1457784159 · GRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 89 payments from 16 companies in 2025. Trend: 2023 $1,120 · 2024 $1,407 · 2025 $1,463
Food & beverage: $1,463
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $216 |
| ABBVIE INC. | 14 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $160 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Indivior Inc. | 7 | $138 |
| Ardelyx, Inc. | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Alkermes, Inc. | 3 | $69 |
| Axsome Therapeutics, Inc. | 3 | $61 |
Products named: CAPLYTA, SUBLOCADE, RELISTOR, IBSRELA, HETLIOZ, MAVYRET, ARISTADA, Auvelity.
Industry payments across KY — which companies pay providers there.
